The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
Q&A with Safkhet's Fahmi Quadir: 'I love investigating frauds and making money at their expense''
Valeant bonds facing crisis of confidence
Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham Transactions
Valeant shares recoup losses after company rejects short seller report - MarketWatch
Watch Valeant Short Seller Picks Next Target - Bloomberg
Netflix Dirty Money — An Interview With Erin Lee Carr
The 'Short' Who Sank Valeant Stock - WSJ
Short seller who foresaw Valeant crash now bets on Tesla falling
What the Average Short Position in Valeant
Dirty Money" Drug Short (TV Episode 2018) - IMDb
Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg
Former Valeant CEO unloaded more shares than previously thought
The short seller who bet big against Valeant has turned bullish on the company he helped bring down - The Globe and Mail
What the Average Short Position in Valeant
The rise and fall of Valeant Pharmaceuticals | CBC News
Is the hate for short-sellers justified as Canadian companies like D+H, Valeant become targets? | Financial Post
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
Citron Research Report Is Out
Short seller who foresaw Valeant crash now bets on Tesla falling - Moneyweb
Bids for Valeant subsidiary iNova fall short of expectations | The Australian
Citron Short Valeant Again
Short Selling In Stock Market | Valeant Pharmaceuticals in മലയാളം | KUKU FM
Valeant Plunges 30% After Short Seller Citron Research Makes Fraud Allegation
The 'Short' Who Sank Valeant Stock - WSJ
